Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients

Diabetologia

Volumn 53, Issue 6, 2010, Pages 1151-1163

  Aguer, C ^a,b,g   Mercier, J ^a,b,c   Yong Wai Man, C ^a,b   Metz, L ^a,b   Bordenave, S ^a,b   Lambert, K ^a,b   Jean, E ^a,b   Lantier, L ^a,d   Bounoua, L ^e   Brun, J F ^a,b,c   Raynaud De Mauverger, E ^a,b,c   Andreelli, F ^a,d,f   Foretz, M ^a,d   Kitzmann, M ^a,b  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c LAPEYRONIE HOSPITAL   (France)

^d INSTITUT COCHIN   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f BICHAT HOSPITAL   (France)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Human myotubes; Lipid; Obesity; Skeletal muscle; Type 2 diabetes

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CD36 ANTIGEN; CITRATE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIPID STORAGE; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; ANTIGENS, CD36; BLOTTING, WESTERN; BODY FAT DISTRIBUTION; CELLS, CULTURED; CITRATE (SI)-SYNTHASE; DIABETES MELLITUS, TYPE 2; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; WAIST CIRCUMFERENCE;

EID: 77952090390     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1708-x     Document Type: Article

References (49)

1. KF Petersen S Dufour D Befroy R Garcia GI Shulman 2004 Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes N Engl J Med 350 664 671 10.1056/NEJMoa031314 1:CAS:528: DC%2BD2cXhtFCrtrc%3D 14960743 (Pubitemid 38364625)
2. C Thamer J Machann O Bachmann, et al. 2003 Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity J Clin Endocrinol Metab 88 1785 1791 10.1210/jc.2002-021674 1:CAS:528:DC%2BD3sXjtFClt70%3D 12679474 (Pubitemid 36623405)
3. R Weiss S Dufour A Groszmann, et al. 2003 Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation J Clin Endocrinol Metab 88 2014 2018 10.1210/jc.2002-021711 1:CAS:528: DC%2BD3sXjs1Okt7s%3D 12727947 (Pubitemid 36549870)
4. LJ van Loon R Koopman R Manders W van der Weegen GP van Kranenburg HA Keizer 2004 Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes Am J Physiol Endocrinol Metab 287 E558 E565 10.1152/ajpendo.00464.2003 15165998 (Pubitemid 39095892)
5. MW Hulver JR Berggren MJ Carper, et al. 2005 Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans Cell Metab 2 251 261 10.1016/j.cmet.2005.09.002 1:CAS:528:DC%2BD2MXhtFGktrjP 16213227
6. B Ukropcova M McNeil O Sereda, et al. 2005 Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor J Clin Invest 115 1934 1941 10.1172/JCI24332 1:CAS:528: DC%2BD2MXlvF2qtL0%3D 16007256 (Pubitemid 40979733)
7. M Gaster AC Rustan V Aas H Beck-Nielsen 2004 Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes Diabetes 53 542 548 10.2337/diabetes.53.3.542 1:CAS:528:DC%2BD2cXhvFelur8%3D 14988236 (Pubitemid 38270621)
8. DE Kelley J He EV Menshikova VB Ritov 2002 Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes Diabetes 51 2944 2950 10.2337/diabetes.51.10.2944 1:CAS:528:DC%2BD38XnslGhsrY%3D 12351431
9. M Mogensen K Sahlin M Fernstrom, et al. 2007 Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes Diabetes 56 1592 1599 10.2337/db06-0981 1:CAS:528:DC%2BD2sXmtlKhsrg%3D 17351150 (Pubitemid 46842617)
10. A Bonen ML Parolin GR Steinberg, et al. 2004 Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36 FASEB J 18 1144 1146 1:CAS:528:DC%2BD2cXlslKktrY%3D 15132977 (Pubitemid 39561551)
11. E Phielix VB Schrauwen-Hinderling M Mensink, et al. 2008 Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients Diabetes 57 2943 2949 10.2337/db08-0391 1:CAS:528:DC%2BD1MXhsleju7c%3D 18678616
12. DE Befroy KF Petersen S Dufour, et al. 2007 Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients Diabetes 56 1376 1381 10.2337/db06-0783 1:CAS:528:DC%2BD2sXltlanurc%3D 17287462 (Pubitemid 46715630)
13. JA Hawley SJ Lessard 2008 Exercise training-induced improvements in insulin action Acta Physiol (Oxf) 192 127 135 1:CAS:528:DC%2BD1cXhsVaisrk%3D
14. N Dzamko JD Schertzer JG Ryall, et al. 2008 AMPK-independent pathways regulate skeletal muscle fatty acid oxidation J Physiol 586 5819 5831 10.1113/jphysiol.2008.159814 1:CAS:528:DC%2BD1cXhsFemt7jF 18845612
15. R Boushel E Gnaiger P Schjerling M Skovbro R Kraunsoe F Dela 2007 Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle Diabetologia 50 790 796 10.1007/s00125-007-0594-3 1:CAS:528: DC%2BD2sXitlOntbY%3D 17334651 (Pubitemid 46355830)
16. HM De Feyter NM van den Broek SF Praet K Nicolay LJ van Loon JJ Prompers 2008 Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction Eur J Endocrinol 158 643 653 10.1530/EJE-07-0756 18426822 (Pubitemid 351639601)
17. CT Coburn FF Knapp Jr M Febbraio AL Beets RL Silverstein NA Abumrad 2000 Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice J Biol Chem 275 32523 32529 10.1074/jbc. M003826200 1:CAS:528:DC%2BD3cXnslOitrY%3D 10913136
18. GP Holloway AB Thrush GJ Heigenhauser, et al. 2007 Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women Am J Physiol Endocrinol Metab 292 E1782 E1789 10.1152/ajpendo.00639. 2006 1:CAS:528:DC%2BD2sXmvF2mtb4%3D 17311893 (Pubitemid 47084714)
19. GP Holloway CR Benton KL Mullen, et al. 2009 In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation Am J Physiol Endocrinol Metab 296 E738 E747 10.1152/ajpendo.90896.2008 1:CAS:528:DC%2BD1MXkvVyht7g%3D 19141681
20. LE Voorrips AC Ravelli PC Dongelmans P Deurenberg WA Van Staveren 1991 A physical activity questionnaire for the elderly Med Sci Sports Exerc 23 974 979 1:STN:280:DyaK38%2FmsFOrtQ%3D%3D 1956274
21. JF Brun R Guintrand-Hugret C Boegner O Bouix A Orsetti 1995 Influence of short-term submaximal exercise on parameters of glucose assimilation analyzed with the minimal model Metabolism 44 833 840 10.1016/0026-0495(95)90234-1 1:CAS:528:DyaK2MXmvVGgt7s%3D 7616840
22. C Thomas P Sirvent S Perrey E Raynaud J Mercier 2004 Relationships between maximal muscle oxidative capacity and blood lactate removal after supramaximal exercise and fatigue indexes in humans J Appl Physiol 97 2132 2138 10.1152/japplphysiol.00387.2004 1:CAS:528:DC%2BD2MXivFKl 15208291 (Pubitemid 39552452)
23. C Thomas S Perrey K Lambert G Hugon D Mornet J Mercier 2005 Monocarboxylate transporters, blood lactate removal after supramaximal exercise, and fatigue indexes in humans J Appl Physiol 98 804 809 10.1152/japplphysiol. 01057.2004 1:CAS:528:DC%2BD2MXisVCjsro%3D 15531559 (Pubitemid 40283657)
24. DR Wood JS Nye NJ Lamb A Fernandez M Kitzmann 2005 Intracellular retention of caveolin 1 in presenilin-deficient cells J Biol Chem 280 6663 6668 10.1074/jbc.M410332200 1:CAS:528:DC%2BD2MXhsV2qsbY%3D 15613480 (Pubitemid 40341219)
25. M Gaster H Beck-Nielsen 2006 Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects Biochim Biophys Acta 1761 100 110 1:CAS:528:DC%2BD28Xit1Ohu7c%3D 16442843 (Pubitemid 44175824)
26. C Aguer J Mercier M Kitzmann 2010 Lipid content and response to insulin are not invariably linked in human muscle cells Mol Cell Endocrinol 315 225 232 10.1016/j.mce.2009.10.017 1:CAS:528:DC%2BD1MXhsFymsL%2FO 19897010
27. M Kitzmann A Bonnieu C Duret, et al. 2006 Inhibition of Notch signaling induces myotube hypertrophy by recruiting a subpopulation of reserve cells J Cell Physiol 208 538 548 10.1002/jcp.20688 1:CAS:528:DC%2BD28XnvFWmsrk%3D 16741964 (Pubitemid 44141878)
28. DA Pan S Lillioja AD Kriketos, et al. 1997 Skeletal muscle triglyceride levels are inversely related to insulin action Diabetes 46 983 988 10.2337/diabetes.46.6.983 1:CAS:528:DyaK2sXjsVKhtrk%3D 9166669 (Pubitemid 27220998)
29. G Perseghin P Scifo F De Cobelli, et al. 1999 Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents Diabetes 48 1600 1606 10.2337/diabetes.48.8.1600 1:CAS:528:DyaK1MXkvVKmsrw%3D 10426379 (Pubitemid 29356869)
30. MR Munday 2002 Regulation of mammalian acetyl-CoA carboxylase Biochem Soc Trans 30 1059 1064 10.1042/BST0301059 1:CAS:528:DC%2BD38XovF2isbk%3D 12440972 (Pubitemid 36002406)
31. JJ Luiken DJ Dyck XX Han, et al. 2002 Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane Am J Physiol Endocrinol Metab 282 E491 E495 1:CAS:528:DC%2BD38XhtFGitbg%3D 11788383
32. A Bonen JJ Luiken Y Arumugam JF Glatz NN Tandon 2000 Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase J Biol Chem 275 14501 14508 10.1074/jbc.275.19.14501 1:CAS:528: DC%2BD3cXjt1Cnsbk%3D 10799533 (Pubitemid 30339737)
33. HA Keizer G Schaart NN Tandon JF Glatz JJ Luiken 2004 Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres Histochem Cell Biol 121 101 107 10.1007/s00418-003-0615-3 1:CAS:528:DC%2BD2cXhsFeqtr0%3D 14740222 (Pubitemid 38316652)
34. B Vistisen K Roepstorff C Roepstorff A Bonen B van Deurs B Kiens 2004 Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers J Lipid Res 45 603 609 10.1194/jlr.M300424-JLR200 1:CAS:528:DC%2BD2cXjtFWmsL8%3D 14729862 (Pubitemid 38405665)
35. SL Coort J Willems WA Coumans, et al. 2002 Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake Mol Cell Biochem 239 213 219 10.1023/A:1020539932353 1:CAS:528:DC%2BD38Xns1Sgu7g%3D 12479588 (Pubitemid 35385812)
36. JY Kim RC Hickner RL Cortright GL Dohm JA Houmard 2000 Lipid oxidation is reduced in obese human skeletal muscle Am J Physiol Endocrinol Metab 279 E1039 E1044 1:CAS:528:DC%2BD3cXotFaqs7w%3D 11052958
37. HM De Feyter E Lenaers SM Houten, et al. 2008 Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes FASEB J 22 3947 3955 10.1096/fj.08-112318 18653763
38. N Turner CR Bruce SM Beale, et al. 2007 Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents Diabetes 56 2085 2092 10.2337/db07-0093 1:CAS:528:DC%2BD2sXos12qsL0%3D 17519422 (Pubitemid 47195821)
39. KS Nair ML Bigelow YW Asmann, et al. 2008 Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance Diabetes 57 1166 1175 10.2337/db07-1556 1:CAS:528: DC%2BD1cXlvVKjt7w%3D 18285554
40. GR Steinberg AC Smith BJ Van Denderen, et al. 2004 AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females J Clin Endocrinol Metab 89 4575 4580 10.1210/jc.2004-0308 1:CAS:528: DC%2BD2cXnslWhtbs%3D 15356065 (Pubitemid 39244472)
41. K Hojlund KJ Mustard P Staehr, et al. 2004 AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes Am J Physiol Endocrinol Metab 286 E239 E244 10.1152/ajpendo.00326. 2003 1:CAS:528:DC%2BD2cXhsFarsbk%3D 14532170 (Pubitemid 38140315)
42. A Sriwijitkamol DK Coletta E Wajcberg, et al. 2007 Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study Diabetes 56 836 848 10.2337/db06-1119 1:CAS:528:DC%2BD2sXis12itbo%3D 17327455 (Pubitemid 46348486)
43. GK Bandyopadhyay JG Yu J Ofrecio JM Olefsky 2006 Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects Diabetes 55 2277 2285 10.2337/db06-0062 1:CAS:528: DC%2BD28Xot1Ogur0%3D 16873691 (Pubitemid 44743625)
44. A Bonen A Chabowski JJ Luiken JF Glatz 2007 Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence Physiology (Bethesda) 22 15 29 1:CAS:528: DC%2BD2sXjtlajurc%3D
45. V Bezaire CR Bruce GJ Heigenhauser, et al. 2006 Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation Am J Physiol Endocrinol Metab 290 E509 E515 10.1152/ajpendo.00312.2005 1:CAS:528:DC%2BD28Xjt1Sks7o%3D 16219667 (Pubitemid 43671698)
46. JJ Luiken Y Arumugam RC Bell, et al. 2002 Changes in fatty acid transport and transporters are related to the severity of insulin deficiency Am J Physiol Endocrinol Metab 283 E612 E621 1:CAS:528:DC%2BD38XntFOms7Y%3D 12169456 (Pubitemid 35230500)
47. GR Steinberg ML Parolin GJ Heigenhauser DJ Dyck 2002 Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance Am J Physiol Endocrinol Metab 283 E187 E192 1:CAS:528:DC%2BD38XlsVCrt78%3D 12067860
48. GP Holloway JJ Luiken JF Glatz LL Spriet A Bonen 2008 Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview Acta Physiol (Oxf) 194 293 309 10.1111/j.1748-1716.2008.01878.x 1:CAS:528:DC%2BD1cXhsVyqurbM
49. J He S Watkins DE Kelley 2001 Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity Diabetes 50 817 823 10.2337/diabetes.50.4.817 1:CAS:528:DC%2BD3MXisFOjtL4%3D 11289047 (Pubitemid 32242639)